BSE Live
Oct 21, 14:46Prev. Close
2.12
Open Price
2.13
Bid Price (Qty.)
2.13 (274)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Vivanza Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -0.69 | 0.43 | 0.69 | 0.46 | 0.15 | |
| Net CashFlow From Operating Activities | -2.47 | 1.78 | 0.16 | -0.68 | -3.08 | |
| Net Cash Used In Investing Activities | -0.01 | -0.04 | 0.00 | 0.00 | -0.02 | |
| Net Cash Used From Financing Activities | 2.44 | -1.76 | -0.08 | 1.07 | 2.80 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.04 | -0.01 | 0.09 | 0.40 | -0.30 | |
| Cash And Cash Equivalents Begin of Year | 0.09 | 0.10 | 0.02 | -3.11 | -2.81 | |
| Cash And Cash Equivalents End Of Year | 0.05 | 0.09 | 0.10 | -2.72 | -3.11 |
13.05.2025
Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y
13.05.2025
Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y
01.02.2025
Vivanza Bio Consolidated December 2024 Net Sales at Rs 1.50 crore, down 77.13% Y-o-Y
01.02.2025
Vivanza Bio Standalone December 2024 Net Sales at Rs 0.76 crore, down 77.36% Y-o-Y
13.05.2025
Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y
13.05.2025
Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y
01.02.2025
Vivanza Bio Consolidated December 2024 Net Sales at Rs 1.50 crore, down 77.13% Y-o-Y
01.02.2025
Vivanza Bio Standalone December 2024 Net Sales at Rs 0.76 crore, down 77.36% Y-o-Y